Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters

Journal of Neurochemistry

Volumn 85, Issue 6, 2003, Pages 1513-1520

  Kocabas, A M ^a   Rudnick, G ^b   Kilic, F ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Citalopram; Dopamine transporter; Functional and physical association; MTS reagent; Norepinephrine transporter; Serotonin transporter

Indexed keywords

[2 (TRIMETHYLAMMONIUM)ETHYL]METHANETHIOSULFONATE; CITALOPRAM; DOPAMINE TRANSPORTER; MONOMER; MYC PROTEIN; NORADRENALIN TRANSPORTER; PROTEIN; PROTEIN I155C; SEROTONIN TRANSPORTER; THIOL REAGENT; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; OLIGOMERIZATION; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SYNCYTIOTROPHOBLAST;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; BIOGENIC MONOAMINES; CARRIER PROTEINS; CELL MEMBRANE; GENE EXPRESSION; HELA CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MESYLATES; MOLECULAR SEQUENCE DATA; MUTATION; NERVE TISSUE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PRECIPITIN TESTS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT FUSION PROTEINS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SULFHYDRYL REAGENTS; SYMPORTERS; TRANSFECTION;

EID: 0037795732     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01793.x     Document Type: Article

References (35)

1. Amara S. and Kuhar M. (1993) Neurotransmitter transporters - recent progress. Annu. Rev. Neurosci. 16, 73-93.
2. Androutsellis-Theotokis A. and Rudnick G. (2002) Accessibility and conformational coupling in serotonin transporter predicted internal domains. J. Neurosci. 22, 8370-8378.
3. Balkovetz D. F., Tirruppathi C., Leibach F. H., Mahesh V. B. and Ganapathy V. (1989) Evidence for an imipramine-sensitive serotonin transporter in human placental brush-border membranes. J. Biol. Chem. 264, 2195-2198.
4. Bauman P. A. and Blakely R. D. (2002) Determinants within the C-terminus of the human norepinephrine transporter dictate transporter trafficking, stability, and activity. Arch. Biochem. Biophys. 404, 80-91.
5. Blakely R., Berson H., Fremeau R., Caron M., Peek M., Prince H. and Bradely C. (1991a) Cloning and expression of a functional serotonin transporter from rat brain. Nature 354, 66-70.
6. Blakely R. D., Clark J. A., Rudnick G. and Amara S. G. (1991b) Vaccinia-T7 RNA polymerase expression system. Evaluation for expression cloning plasma membrane transporters. Anal. Biochem. 194, 302-308.
7. Bruss M., Hammermann R., Brimijoin S. and Bonisch H. (1995) Antipeptide antibodies confirm the topology of the human norepinephrine transporter. J. Biol. Chem. 270, 9197-9201.
8. Burton L. D., Kippenberger A. G., Lingen B., Bruss M., Bonisch H. and Christie D. L. (1998) A variant of the bovine noradrenaline transporter reveals the importance of the C-terminal region for correct targeting to the membrane and functional expression. Biochem. J. 330, 909-914.
9. Chang A. S., Starnes D. M. and Chang S. M. (1998) Possible existence of quaternary structure in the high-affinity serotonin transport complex. Biochem. Biophys. Res. Commun. 249, 416-421.
10. Chen J. G. and Rudnick G. (2000) Permeation and gating residues in serotonin transporter. Proc. Natl Acad. Sci. USA 97, 1044-1049.
11. Chen J. G., Sachpatzidis A. and Rudnick G. (1997) The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding. J. Biol. Chem. 272, 28 321-28 327.
12. Chen J. G., Liu-Chen S. and Rudnick G. (1998) Determination of external loop topology in the serotonin transporter by site-directed chemical labeling. J. Biol. Chem. 273, 12 675-12 681.
13. Ferrer J. V. and Javitch J. A. (1998) Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter. Proc. Natl Acad. Sci. USA 95, 9238-9243.
14. Fleckenstein A. E., Gibb J. W. and Hanson G. R. (2000) Differential effects of stimulants on monoaminergic transporters: Pharmacological consequences and implications for neurotoxicity. Eur. J. Pharmacol. 406, 1-13.
15. Fuerst T. R., Niles E. G., Studier F. W. and Moss B. (1986) Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl Acad. Sci. USA 83, 8122-8126.
16. Gottardi C., Dunbar L. and Caplan M. (1995) Biotinylation and assessment of membrane polarity - caveats and methodological concerns. Am. J. Physiol. 268, F285-F295.
17. Guastella J., Nelson N., Nelson H., Czyzyk L., Keynan S., Miedel M., Davidson N., Lester H. and Kanner B. I. (1990) Cloning and expression of a rat brain GABA transporter. Science 249, 1303-1306.
18. Hastrup H., Karlin A. and Javitch J. A. (2001) Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment. Proc. Natl Acad. Sci. USA 98, 10 055-10 060.
19. Hersch S. M., Yi H., Heilman C. J., Edwards R. H. and Levey A. I. (1997) Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J. Comp. Neurol. 388, 211-227.
20. Jess U., Betz H. and Schloss P. (1996) The membrane-bound rat serotonin transporter, Sert1, is an oligomeric protein. FEBS. Lett. 394, 44-46.
21. Kilic F. and Rudnick G. (2000) Oligomerization of serotonin transporter and its functional consequences. Proc. Natl Acad. Sci. USA 97, 3106-3111.
22. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
23. Leonard B. E. (1999) Neuropharmacology of antidepressants that modify central noradrenergic and serotonergic function: A short review. Human Psychopharmacology 14, 75-81.
24. Lester H. A., Mager S., Quick M. W. and Corey J. L. (1994) Permeation properties of neurotransmitter transporters. Annu. Rev. Pharmacol. Toxicol. 34, 219-249.
25. Melikian H., McDonald J., Gu H., Rudnick G., Moore K. and Blakely R. (1994) Human norepinephrine transporter: Biosynthetic studies using a site-directed polyclonal antibody. J. Biol. Chem. 269, 12 290-12 297.
26. Nelson N. (1998) The family of Na+/Cl-neurotransmitter transporters. J. Neurochem. 71, 1785-1803.
27. Pacholczyk T., Blakely R. and Amara S. (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350, 350-354.
28. Ramamoorthy S., Prasad P., Kulanthaivel P., Leibach F. H., Blakely R. D. and Ganapathy V. (1993) Expression of a cocaine-sensitive norepinephrine transporter in the human placental syncytiotrophoblast. Biochem. J. 32, 1346-1353.
29. Saier M. H. (1999) A functional-phylogenetic system for the classification of transport proteins. J. Cell. Biochem. Suppl. 32-33, 84-94.
30. Schmid J. A., Scholze P., Kudlacek O., Freissmuth M., Singer E. A. and Sitte H. H. (2001) Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells. J. Biol. Chem. 276, 3805-3810.
31. Schroeter S., Apparsundaram S., Wiley R. G., Miner L. H., Sesack S. R. and Blakely R. D. (2000) Immunolocalization of the cocaine- and antidepressant-sensitive 1-norepinephrine transporter. J. Comp. Neurol. 420, 211-232.
32. Shimada S., Kitayama S., Lin C., Patel A., Nanthakumar E., Gregor P., Kuhar M. and Uhl G. (1991) Cloning and expression of a cocainesensitive dopamine transporter complementary DNA. Science 254, 576-578.
33. Talvenheimo J. and Rudnick G. (1980) Solubilization of the platelet plasma membrane the serotonin transporter in an active form. J. Biol. Chem. 255, 8606-8611.
34. Torres G. E., Carneiro A., Seamans K., Fiorentini C., Sweeney A., Yao W. D. and Caron M. G. (2003) Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J. Biol. Chem. 278, 2731-2739.
35. Towbin H., Staehelin T. and Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA 76, 4350-4354.